二甲双胍：“再战新征程的老将” - Suppr

Suppr

超能文献

Metformin: "Old warrior for a new battle".

作者信息

Jain A

出版信息

Indian J Cancer. 2010 Oct-Dec;47(4):471-2. doi: 10.4103/0019-509X.73553.

DOI:10.4103/0019-509X.73553

PMID:21131766

Abstract

摘要

相似文献

Metformin: "Old warrior for a new battle".

Indian J Cancer. 2010 Oct-Dec;47(4):471-2. doi: 10.4103/0019-509X.73553.

Evaluation of metformin in early breast cancer: a modification of the traditional paradigm for clinical testing of anti-cancer agents.

Breast Cancer Res Treat. 2011 Feb;126(1):215-20. doi: 10.1007/s10549-010-1224-1. Epub 2010 Oct 26.

Clinical outcomes after radical prostatectomy in diabetic patients treated with metformin.

Urology. 2010 Nov;76(5):1240-4. doi: 10.1016/j.urology.2010.03.059.

Metformin as an addition to conventional chemotherapy in breast cancer.

J Clin Oncol. 2009 Dec 10;27(35):e259; author reply e260. doi: 10.1200/JCO.2009.25.4110. Epub 2009 Nov 2.

Anticancer effects of metformin and its potential use as a therapeutic agent for breast cancer.

Future Oncol. 2011 Jun;7(6):727-36. doi: 10.2217/fon.11.49.

Long-term metformin use is associated with decreased risk of breast cancer.

Diabetes Care. 2010 Jun;33(6):1304-8. doi: 10.2337/dc09-1791. Epub 2010 Mar 18.

Is it time to test metformin in breast cancer prevention trials? A reply to the authors.

Cancer Epidemiol Biomarkers Prev. 2009 Sep;18(9):2565; author reply 2565. doi: 10.1158/1055-9965.EPI-09-0515.

Metformin: fifty-two not out.

J Indian Med Assoc. 2009 Nov;107(11):779-84.

Metformin, B(12), and enhanced breast cancer response to chemotherapy.

J Clin Oncol. 2010 Jan 10;28(2):e19; author reply e20. doi: 10.1200/JCO.2009.25.7857. Epub 2009 Nov 30.

Metformin: an old drug with new potential.

Expert Opin Investig Drugs. 2013 Dec;22(12):1511-7. doi: 10.1517/13543784.2013.833604. Epub 2013 Aug 26.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Metformin: "Old warrior for a new battle".

Indian J Cancer. 2010 Oct-Dec;47(4):471-2. doi: 10.4103/0019-509X.73553.

Evaluation of metformin in early breast cancer: a modification of the traditional paradigm for clinical testing of anti-cancer agents.

Breast Cancer Res Treat. 2011 Feb;126(1):215-20. doi: 10.1007/s10549-010-1224-1. Epub 2010 Oct 26.

Clinical outcomes after radical prostatectomy in diabetic patients treated with metformin.

Urology. 2010 Nov;76(5):1240-4. doi: 10.1016/j.urology.2010.03.059.

Metformin as an addition to conventional chemotherapy in breast cancer.

J Clin Oncol. 2009 Dec 10;27(35):e259; author reply e260. doi: 10.1200/JCO.2009.25.4110. Epub 2009 Nov 2.

Anticancer effects of metformin and its potential use as a therapeutic agent for breast cancer.

Future Oncol. 2011 Jun;7(6):727-36. doi: 10.2217/fon.11.49.

Long-term metformin use is associated with decreased risk of breast cancer.

Diabetes Care. 2010 Jun;33(6):1304-8. doi: 10.2337/dc09-1791. Epub 2010 Mar 18.

Is it time to test metformin in breast cancer prevention trials? A reply to the authors.

Cancer Epidemiol Biomarkers Prev. 2009 Sep;18(9):2565; author reply 2565. doi: 10.1158/1055-9965.EPI-09-0515.

Metformin: fifty-two not out.

J Indian Med Assoc. 2009 Nov;107(11):779-84.

Metformin, B(12), and enhanced breast cancer response to chemotherapy.

J Clin Oncol. 2010 Jan 10;28(2):e19; author reply e20. doi: 10.1200/JCO.2009.25.7857. Epub 2009 Nov 30.

Metformin: an old drug with new potential.

Expert Opin Investig Drugs. 2013 Dec;22(12):1511-7. doi: 10.1517/13543784.2013.833604. Epub 2013 Aug 26.